MethylPREDNISolone TABLETS, USP 4 mg, a) 100 count bottles (NDC 0603-4593-21) and b) 21 count bl...
FDA Drug Recall #D-1605-2014 — Class III — September 11, 2014
Recall Summary
| Recall Number | D-1605-2014 |
| Classification | Class III — Low risk |
| Date Initiated | September 11, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Qualitest Pharmaceuticals |
| Location | Huntsville, AL |
| Product Type | Drugs |
| Quantity | 159,913 tablets |
Product Description
MethylPREDNISolone TABLETS, USP 4 mg, a) 100 count bottles (NDC 0603-4593-21) and b) 21 count blister pack (NDC 0603-4593-15), Rx only, Mfg for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811
Reason for Recall
Subpotent; 6 month stability time point
Distribution Pattern
Nationwide
Lot / Code Information
100 count: T147F13A, Exp. 05/2015; 21 count: S003M14, Exp. 05/2015
Other Recalls from Qualitest Pharmaceuticals
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1405-2015 | Class III | ALLOPURINOL TABLETS, USP, 300 mg, 500 count bot... | Jul 20, 2015 |
| D-1239-2015 | Class III | HydrOXYzine Hydrochloride Tablets, USP 25 mg, ... | Jun 29, 2015 |
| D1151-2015 | Class III | Disulfiram tablets, USP, 500 mg, 100-count bott... | Jun 18, 2015 |
| D00432-2015 | Class III | PROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml c... | Mar 25, 2015 |
| D-0411-2015 | Class II | PROMETHAZINE DM SYRUP (Promethazine Hydrochlori... | Feb 23, 2015 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.